Hashimoto encephalopathy: a rare intricate syndrome
Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed "Hashimoto encephalopathy" (HE). Althoug...
Gespeichert in:
Veröffentlicht in: | International journal of endocrinology and metabolism 2012-01, Vol.10 (2), p.506-514 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 514 |
---|---|
container_issue | 2 |
container_start_page | 506 |
container_title | International journal of endocrinology and metabolism |
container_volume | 10 |
creator | Payer, Juraj Petrovic, Tomas Lisy, Lubomir Langer, Pavel |
description | Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed "Hashimoto encephalopathy" (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade. |
doi_str_mv | 10.5812/ijem.4174 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3693614</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23843812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c342t-467aa97c3e666d3fe5eb74954f182bd424afe7373201ad0d9829290937116ad73</originalsourceid><addsrcrecordid>eNpVkEFLxDAQhYMo7rp68A9Irx66Jpk0aTwIsqgrLHhR8BZmm9R22TYlqcL-e1tWFz3NwLz35vERcsnoPMsZv6k3rpkLpsQRmTLFZaqZyI8PO7xPyFmMG0ozmSt5SiYccgGDc0pgibGqG9_7xLWF6yrc-g77anebYBIwuKRu-1AX2Lsk7lobfOPOyUmJ2-gufuaMvD0-vC6W6erl6Xlxv0oLELxPhVSIWhXgpJQWSpe5tRI6EyXL-doKLrB0ChRwytBSq3OuuaYaFGMSrYIZudvndp_rxtnCDU1wa7pQNxh2xmNt_l_aujIf_suA1CCZGAKu9wFF8DEGVx68jJqRnBnJmZHcoL36--yg_EUF38PyaoA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hashimoto encephalopathy: a rare intricate syndrome</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Payer, Juraj ; Petrovic, Tomas ; Lisy, Lubomir ; Langer, Pavel</creator><creatorcontrib>Payer, Juraj ; Petrovic, Tomas ; Lisy, Lubomir ; Langer, Pavel</creatorcontrib><description>Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed "Hashimoto encephalopathy" (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade.</description><identifier>ISSN: 1726-913X</identifier><identifier>EISSN: 1726-9148</identifier><identifier>DOI: 10.5812/ijem.4174</identifier><identifier>PMID: 23843812</identifier><language>eng</language><publisher>Iran: Kowsar</publisher><subject>Case Report</subject><ispartof>International journal of endocrinology and metabolism, 2012-01, Vol.10 (2), p.506-514</ispartof><rights>Copyright © 2012, Research Institute For Endocrine Sciences and Iran Endocrine Society 2012</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c342t-467aa97c3e666d3fe5eb74954f182bd424afe7373201ad0d9829290937116ad73</citedby><cites>FETCH-LOGICAL-c342t-467aa97c3e666d3fe5eb74954f182bd424afe7373201ad0d9829290937116ad73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693614/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693614/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23843812$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Payer, Juraj</creatorcontrib><creatorcontrib>Petrovic, Tomas</creatorcontrib><creatorcontrib>Lisy, Lubomir</creatorcontrib><creatorcontrib>Langer, Pavel</creatorcontrib><title>Hashimoto encephalopathy: a rare intricate syndrome</title><title>International journal of endocrinology and metabolism</title><addtitle>Int J Endocrinol Metab</addtitle><description>Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed "Hashimoto encephalopathy" (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade.</description><subject>Case Report</subject><issn>1726-913X</issn><issn>1726-9148</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpVkEFLxDAQhYMo7rp68A9Irx66Jpk0aTwIsqgrLHhR8BZmm9R22TYlqcL-e1tWFz3NwLz35vERcsnoPMsZv6k3rpkLpsQRmTLFZaqZyI8PO7xPyFmMG0ozmSt5SiYccgGDc0pgibGqG9_7xLWF6yrc-g77anebYBIwuKRu-1AX2Lsk7lobfOPOyUmJ2-gufuaMvD0-vC6W6erl6Xlxv0oLELxPhVSIWhXgpJQWSpe5tRI6EyXL-doKLrB0ChRwytBSq3OuuaYaFGMSrYIZudvndp_rxtnCDU1wa7pQNxh2xmNt_l_aujIf_suA1CCZGAKu9wFF8DEGVx68jJqRnBnJmZHcoL36--yg_EUF38PyaoA</recordid><startdate>20120101</startdate><enddate>20120101</enddate><creator>Payer, Juraj</creator><creator>Petrovic, Tomas</creator><creator>Lisy, Lubomir</creator><creator>Langer, Pavel</creator><general>Kowsar</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120101</creationdate><title>Hashimoto encephalopathy: a rare intricate syndrome</title><author>Payer, Juraj ; Petrovic, Tomas ; Lisy, Lubomir ; Langer, Pavel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c342t-467aa97c3e666d3fe5eb74954f182bd424afe7373201ad0d9829290937116ad73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Case Report</topic><toplevel>online_resources</toplevel><creatorcontrib>Payer, Juraj</creatorcontrib><creatorcontrib>Petrovic, Tomas</creatorcontrib><creatorcontrib>Lisy, Lubomir</creatorcontrib><creatorcontrib>Langer, Pavel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Payer, Juraj</au><au>Petrovic, Tomas</au><au>Lisy, Lubomir</au><au>Langer, Pavel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hashimoto encephalopathy: a rare intricate syndrome</atitle><jtitle>International journal of endocrinology and metabolism</jtitle><addtitle>Int J Endocrinol Metab</addtitle><date>2012-01-01</date><risdate>2012</risdate><volume>10</volume><issue>2</issue><spage>506</spage><epage>514</epage><pages>506-514</pages><issn>1726-913X</issn><eissn>1726-9148</eissn><abstract>Recently, several patients have been reported with various signs of encephalopathy and high thyroid antibody levels together with good responsiveness to glucocorticoid therapy. Despite the various clinical presentations, these cases have been termed "Hashimoto encephalopathy" (HE). Although all of the pathogenic components have not yet been clearly elucidated, it is believed that brain vasculitis and autoimmunity directed against common brain-thyroid antigens represent the most likely etiologic pathway. The most common clinical signs include unexplained or epilepsy-like seizures resistant to anti-convulsive treatment, confusion, headaches, hallucinations, stroke-like episodes, coma, impairment of cognitive function, behavioral and mood disturbance, focal neurological deficits, disturbance of consciousness, ataxia, and presenile dementia, together with the presence of high thyroid antibody levels, especially against thyroperoxidase (TPOab). In most cases, the thyroid function is normal or decreased; the thyroid function is rarely increased. The examination of the cerebrospinal fluid, EEG, MRI, SPECT, and neuropsychological examinations are primarily used as diagnostic tools. Most cases showed neural symptoms for months before the acute onset; in some cases, a dramatic acute onset was described. Once the diagnosis is made, corticosteroid treatment usually provides a dramatic recovery. The authors also present a short review of literary cases reported in last decade.</abstract><cop>Iran</cop><pub>Kowsar</pub><pmid>23843812</pmid><doi>10.5812/ijem.4174</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1726-913X |
ispartof | International journal of endocrinology and metabolism, 2012-01, Vol.10 (2), p.506-514 |
issn | 1726-913X 1726-9148 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3693614 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | Case Report |
title | Hashimoto encephalopathy: a rare intricate syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T21%3A22%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hashimoto%20encephalopathy:%20a%20rare%20intricate%20syndrome&rft.jtitle=International%20journal%20of%20endocrinology%20and%20metabolism&rft.au=Payer,%20Juraj&rft.date=2012-01-01&rft.volume=10&rft.issue=2&rft.spage=506&rft.epage=514&rft.pages=506-514&rft.issn=1726-913X&rft.eissn=1726-9148&rft_id=info:doi/10.5812/ijem.4174&rft_dat=%3Cpubmed_cross%3E23843812%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23843812&rfr_iscdi=true |